(lp0
S'Just the Facts on Alexion Pharmaceuticals, Inc.  StockNewsJournal - 14 hours ago Alexion Pharmaceuticals, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology.Alexion Pharma names former Baxalta chief Ludwig Hantson CEO - ReutersAlexion Pharmaceuticals, Inc. closed with a change of -0.36% in the Previous ... - Free Observer'
p1
aS'Orbimed Advisors Llc Buys Anthem, Alexion Pharmaceuticals, Aetna, Sells ... GuruFocus.com - 6 hours ago New York, NY, based Investment company Orbimed Advisors Llc buys Anthem, Alexion Pharmaceuticals, Aetna, Humana, Synergy Pharmaceuticals, Merck, Pfizer, HCA Holdings, Eli Lilly and Co, Momenta Pharmaceuticals, sells WellCare Health Plans,&nbsp;...'
p2
aS'Why to Keeping Eye on Alexion Pharmaceuticals, Inc. , Sally Beauty ... StockNewsJournal - Mar 27, 2017 ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.Looking at book value of Annaly Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN ... - The Finance Registrar'
p3
aS"Jim Cramer Weighs In On Alexion Pharmaceuticals And Lowe's Companies Benzinga - Mar 8, 2017 On CNBC's Mad Money, Jim Cramer said that Alexion Pharmaceuticals, Inc.  is a takeover target, but he can't recommend it just on takeover basis.Alexion Pharma  Founder to Retire as Chairman and Board Member - StreetInsider.comBuy or Sell? What Analysts Recommends: The TJX Companies, Inc. , Alexion ... - StockNewsJournal"
p4
aS'Alexion Pharmaceuticals Enters Oversold Territory  Nasdaq - Mar 21, 2017 In trading on Tuesday, shares of Alexion Pharmaceuticals Inc.  entered into oversold territory, hitting an RSI reading of 28.0, after changing hands as low as $117.57 per share.'
p5
aS'Commit To Buy Alexion Pharmaceuticals At $75, Earn 5.1% Using Options Nasdaq - Mar 22, 2017 Investors considering a purchase of Alexion Pharmaceuticals Inc.  stock, but cautious about paying the going market price of $119.16/share, might benefit from considering selling puts among the alternative strategies at their disposal.'
p6
aS"Analyst's Proposition on Alexion Pharmaceuticals, Inc. , Abercrombie ... The USA Commerce - Mar 27, 2017 Shares of Alexion Pharmaceuticals, Inc.  dropped -0.83% to $119.26. During the trading on 03/24/2017, Company's stock ranged from $121.43 to $118.73."
p7
aS"Alexion  Licenses Artubus Technology for Rare Diseases Yahoo Finance - Mar 17, 2017 Alexion Pharmaceuticals, Inc. ALXN has recently licensed Arbutus Biopharma Corporation's ABUS proprietary lipid nanoparticle  technology for use in one of former's rare disease programs.Stocks Buzz -B&amp;G Foods, Inc. , Alexion Pharmaceuticals, Inc. (NASDAQ ... - Daily News JournalAlexion paying up to $80M to develop new drug - Hartford Business"
p8
aS'Alexion: Weighing The Pros And Cons Seeking Alpha - Feb 28, 2017 The pioneering biotech Alexion  has released Q4 and full-year 2016 earnings and held a conference call that had both positives and negatives.'
p9
aS'Should You Buy, Sell, Or Hold?  Alexion Pharmaceuticals, Inc. , EQT ... USA Commerce Daily - 15 hours ago Shares of Alexion Pharmaceuticals, Inc.  observed rebound of 8.9% since bottoming out at $109.12 on Dec. 13, 2016.'
p10
a.